A new species and a new record of Zoicinae Lehtinen & Hippa, 1979 (Araneae: Lycosidae) from Sumatra Island, with notes on miniaturization in wolf spiders

  A new species and a new record of Zoicinae Lehtinen & Hippa, 1979 (Araneae: Lycosidae) from Sumatra Island, with notes on miniaturization in wolf spiders Abstract A new species of wolf spider, Zoica veloxilla sp. nov., from Sumatra (Indonesia) is described based on both sexes. Lysania pygmaea Thorell, 1890 is recorded from Sumatra for the first time, and its male is illustrated and redescribed. A distribution map for Zoica and Lysania is provided. The problem of miniaturization in wolf spiders is briefly discussed. Based on an analysis of the literature, 32 minute species of wolf spiders in four subfamilies and eleven genera have been reported. The smallest wolf spider known worldwide seems to be Zoica minuta (McKay, 1979) from Australia. Omelko, M.M. & Fomichev, A.A. (2026) A new species and a new record of Zoicinae Lehtinen & Hippa, 1979 (Araneae: Lycosidae) from Sumatra Island, with notes on miniaturization in wolf spiders. Zootaxa, 5869 (2), 339–350. https://doi.o...

Identification and designing an analgesic opioid cyclic peptide from Defensin 4 of Mesobuthus martensii Karsch scorpion venom with more effectiveness than morphine

 


Identification and designing an analgesic opioid cyclic peptide from Defensin 4 of Mesobuthus martensii Karsch scorpion venom with more effectiveness than morphine

Abstract

Considering the limitations of use and side effects of existing analgesics, the discovery of new analgesics is necessary. Venoms of organisms are an important source of analgesic peptides. In this study, using computational biology methods such as molecular docking simulation, molecular dynamics, and predictions of physicochemical and biological properties based on various machine learning algorithms, a non-toxic 9-amino acid peptide from Defensin 4 of Mesobuthus martensii Karsch scorpion venom was discovered for the first time and named Buthicyclin. The peptide was synthesized cyclically by creating a disulfide bond, and its secondary structure was determined by Circular Dichroism (CD). Next, peptide toxicity was evaluated using MTT, hemolysis, and lethal dose (LD50) methods. Subsequently, in animal tests using Tail-flick, Hot plate, and Formalin-induced paw-licking methods, the analgesic effects of Buthicyclin in acute and inflammatory pain were evaluated, and its possible analgesic mechanism was determined. Buthicyclin has a coil-like structure and can be considered a cyclic coil with a disulfide bond. This peptide is non-toxic so its LD50 of this peptide was higher than 20 mg/kg. All analgesic tests showed that Buthicyclin peptide, at 1 mg/kg and 2 mg/kg (significantly greater), was more potent and stable than 2 mg/kg morphine in all time intervals. The results also indicated that Buthicyclin could exert its analgesic effects through binding to opioid receptors. Given the potent and long-lasting analgesic effects of Buthicyclin and its non-toxicity, Buthicyclin can be considered a promising candidate for new analgesic drugs. However, this claim requires more preclinical and clinical trials.
Aliakbari, F., Rahmati, S., Ghanbari, A., Madanchi, H., & Rashidy-Pour, A. (2025). Identification and designing an analgesic opioid cyclic peptide from Defensin 4 of Mesobuthus martensii Karsch scorpion venom with more effectiveness than morphine. Biomedicine & Pharmacotherapy, 188, 118139. https://doi.org/10.1016/j.biopha.2025.118139